KR20050092035A - 신규한 항경련성 유도체 염 - Google Patents

신규한 항경련성 유도체 염 Download PDF

Info

Publication number
KR20050092035A
KR20050092035A KR1020057012509A KR20057012509A KR20050092035A KR 20050092035 A KR20050092035 A KR 20050092035A KR 1020057012509 A KR1020057012509 A KR 1020057012509A KR 20057012509 A KR20057012509 A KR 20057012509A KR 20050092035 A KR20050092035 A KR 20050092035A
Authority
KR
South Korea
Prior art keywords
salt
formula
compound
topiramate
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020057012509A
Other languages
English (en)
Korean (ko)
Inventor
아메드 압델-마기드
신시아 마야노프
Original Assignee
오르토-맥네일 파마슈티칼, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오르토-맥네일 파마슈티칼, 인코퍼레이티드 filed Critical 오르토-맥네일 파마슈티칼, 인코퍼레이티드
Publication of KR20050092035A publication Critical patent/KR20050092035A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020057012509A 2003-01-03 2003-12-30 신규한 항경련성 유도체 염 Ceased KR20050092035A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/336,435 2003-01-03
US10/336,435 US7041650B2 (en) 2001-07-09 2003-01-03 Anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
KR20050092035A true KR20050092035A (ko) 2005-09-16

Family

ID=32710935

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057012509A Ceased KR20050092035A (ko) 2003-01-03 2003-12-30 신규한 항경련성 유도체 염

Country Status (17)

Country Link
US (1) US7041650B2 (https=)
EP (1) EP1581545A1 (https=)
JP (1) JP2006514071A (https=)
KR (1) KR20050092035A (https=)
CN (1) CN100528888C (https=)
AU (1) AU2003300149A1 (https=)
CA (1) CA2511682A1 (https=)
HR (1) HRP20050603A2 (https=)
IL (1) IL169505A0 (https=)
MX (1) MXPA05007253A (https=)
NO (1) NO20053673L (https=)
NZ (1) NZ540696A (https=)
PL (1) PL377766A1 (https=)
RU (1) RU2330041C2 (https=)
UA (1) UA82214C2 (https=)
WO (1) WO2004063210A1 (https=)
ZA (1) ZA200506167B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56108787A (en) * 1980-01-31 1981-08-28 Sato Yakugaku Kenkyusho:Kk Camptothecin coline salt and its preparation
US4513006A (en) 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4751220A (en) * 1986-12-19 1988-06-14 E. R. Squibb & Sons, Inc. Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5753693A (en) * 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
CN100548290C (zh) * 1999-02-24 2009-10-14 辛辛那提大学 氨基磺酸酯衍生物用于治疗冲动控制障碍的用途
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
EP1581545A1 (en) 2005-10-05
ZA200506167B (en) 2007-03-28
PL377766A1 (pl) 2006-02-20
MXPA05007253A (es) 2005-12-14
UA82214C2 (en) 2008-03-25
WO2004063210A1 (en) 2004-07-29
IL169505A0 (en) 2007-07-04
NO20053673L (no) 2005-09-30
US7041650B2 (en) 2006-05-09
US20030176362A1 (en) 2003-09-18
CN100528888C (zh) 2009-08-19
HRP20050603A2 (en) 2006-07-31
CN1735626A (zh) 2006-02-15
RU2330041C2 (ru) 2008-07-27
NZ540696A (en) 2007-11-30
CA2511682A1 (en) 2004-07-29
AU2003300149A1 (en) 2004-08-10
RU2005120782A (ru) 2006-01-20
NO20053673D0 (no) 2005-07-29
JP2006514071A (ja) 2006-04-27

Similar Documents

Publication Publication Date Title
KR20040013127A (ko) 신규한 항경련성 유도체 염
AU2002346042A1 (en) Novel anticonvulsant derivative salts
RU2328502C2 (ru) Новые замещенные сульфаматные противосудорожные производные
WO2018098472A1 (en) Crm1 inhibitors for treating epilepsy
HU219453B (hu) Fruktopiranóz-diacetálok imidátszármazékai és azokat hatóanyagként tartalmazó gyógyászati készítmények, valamint eljárás a készítmények előállítására
KR20050092035A (ko) 신규한 항경련성 유도체 염
EP1838716B1 (en) Olanzapine pamoate dihydrate
CA2511753C (en) Phospholipid derivatives
CN112142716B (zh) 一种5元杂芳基取代的吡嗪衍生物及其应用
HK1064094B (en) Novel anticonvulsant derivative salts
WO2005030698A1 (en) Process for the preparation of voglibose
ZA200402626B (en) New hydroxyalkylindolocarbazole compounds, a process for their preparation and pharmaceutical compositions containing them
CN102918050A (zh) 肠顶端膜钠/磷协同转运的芳基氟磷酸酯抑制剂
RU2793918C2 (ru) Ингибитор некроза клеток, способ его получения и применения
EP0437382A1 (fr) Nouveaux dérivés de la thymidine leur préparation et les compositions qui les contiennent
HK1247726A1 (zh) 烟酰胺核苷的结晶形式

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050701

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081128

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20101216

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110621

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20101216

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I